Tobetsa mona ho bonts'a lifolakha tsa HAO leqepheng lena mme u lefelle katleho feela

Litaba tsa mohala

Marotholi a Mahlo a Metformin bakeng sa Phekolo ea Macular Degeneration

ngotsoeng ke mohlophisi

Curative Biotechnology, Inc. e phatlalalitse kajeno hore k'hamphani e tsoetse pele thutong ea eona ea "Good Laboratory Practice" (GLP) ea toxicology.

Boithuto ba hajoale bo etselitsoe ho lekanya mamello, pharmacokinetics le chefo efe kapa efe ea lehae kapa ea systemic ea metformin e fetotsoeng ha e tsamaisoa ka phano ea mahlo. Boithuto bo tla boela bo hlahlobe kabo ea eona ea lisele tsa mahlo.

Boithuto ba toxicology bo botle ba Laboratori (GLP) ke tlhokahalo bakeng sa faele ea FDA Investigational New Drug (IND).

Mamello ea mahlo e kenyelletsa ho shebisisa litekanyetso, litlhahlobo tse akaretsang tsa bongaka habeli ka letsatsi (tekolo ea boits'oaro / matšoao a kliniki ka hloko e lebisitsoeng mahlo), litlhahlobo tsa mahlo ke ngaka e netefalitsoeng ke Board ea bongaka ba liphoofolo ho latela sekala se fetotsoeng sa Hackett-McDonald le histopathology ea mahlo. .

Tlas'a Tumellano ea Cooperative Research le Development (CRADA), National Eye Institute (NEI) le Curative Biotechnology, Inc. li tla sebelisana 'moho ho lekola tlhahiso ea metformin ea mahlo ea Curative lithutong tsa bongaka bakeng sa kalafo ea ho senyeha ha Macular ho amanang le lilemo tse mahareng le tsa morao-rao. (AMD) lefu.

Litaba Tse Amanang

Mabapi le mongoli

mohlophisi

Mohlophisi e moholo oa eTurboNew ke Linda Hohnholz. O lula ntlong e kholo ea eTN e Honolulu, Hawaii.

Leave a Comment

Arolelana ho...